This present study
investigated the effect of Captisol, a chemically
modified cyclodextrin, on the in vitro dissolution of glimepiride.
We prepared glimepiride–Captisol complexes of different mass
ratios (1:1, 1:2, and 1:3 w/w) by a physical mixing or freeze-drying
technique, and found that complexation with Captisol enhanced the
water solubility of glimepiride. Molecular docking and dynamic simulation
predicted complex formation; at the same time, Fourier transform infrared
spectroscopy, differential scanning calorimetry, powder X-ray diffractometry,
and scanning electron microscope indicated molecular interactions
that support complexation. We also found that an inclusion complex
was better than a physical mixture in enhancing the complexation of
glimepiride with Captisol and enhancing water solubility. Phase solubility
study of the glimepiride–Captisol complex showed an A
L
-type profile, implying the formation of a 1:1 inclusion complex.
The study also revealed that pH influenced the stability of the complex
because the stability constant of the glimepiride–Captisol
complex was higher in distilled water of pH ∼6.0 than in phosphate
buffer of pH 7.2.
We show theoretically that it is possible to form a cold molecular ion from a pair of colliding atom and ion at low energy by photoassociative two-photon Raman processes. We explore the possibility of stimulated Raman adiabatic passage from the continuum of ion-atom scattering states to an ionic molecular state. We provide physical conditions under which coherent population transfer is possible in stimulated Raman photoassociation. Our results are important for experimental realization of PA in ion-atom cold collisions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.